Bioniche Life Sciences Inc

Type: Company

Name: Bioniche Life Sciences Inc

First reported May 22 2013 - Updated May 22 2013 - 3 reports

Bioniche holders Wells, Gubitz slam animal health sale

Today the group of concerned shareholders of . led by William (Bill) M. Wells, former chief executive officer of Biovail Corp., and Greg Gubitz, former general counsel and senior vice-president of corporate development at Biovail, questioned the company's ... [Published Stockwatch - May 22 2013]

Entities: Bioniche Life Sciences Inc, Animal Health, Biovail Corp, Private Equity, Management Team

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Bioniche Life Sciences Q3 net loss decreases

5 minutes ago, 3:05am (ET) 05/22/2013 DatamonitorBioniche Life Sciences Inc., a biopharmaceutical company, has reported that net loss for the third quarter ended March 31, 2013 was C$5.55 million, or C$0.05 loss per share, compared to a net loss of C$5.89 ... [Published Zecco - May 22 2013]

Entities: Bioniche Life Sciences Inc, Graeme McRae, Endo Pharmaceuticals Holdings Incorporated, Bladder Cancer

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Global Operations

Bioniche dissidents add Macci as director nominee

Today the group of concerned shareholders of . led by William (Bill) M. Wells, former chief executive officer of Biovail Corp.; and Greg Gubitz, former general counsel and senior vice-president of corporate development at Biovail, will also nominate Anthony ... [Published Stockwatch - May 21 2013]

Entities: Bioniche Life Sciences Inc, Biovail Corp, Life Science, Global Operations, Biotechnology

First reported May 21 2013 - Updated May 21 2013 - 2 reports

E. coli vaccine maker to shed animal heath arm

The eastern Ontario company that developed a registered vaccine against E. coli O157:H7 bacteria in cattle is working on putting its separate animal health business up for sale.Belleville, Ont.-based Bioniche Life Sciences said last week it has hired ... [Published Thompson Citizen - May 21 2013]

Entities: Animal Health, Bioniche Life Sciences Inc, Vaccine, Escherichia Coli (E. Coli)

First reported May 14 2013 - Updated May 15 2013 - 1 reports

Bioniche Life Sciences shares surge on unit sale talks

Has engaged Evercore Partners to assist in the divestment of its Animal Health businessBioniche Life Sciences (TSX: T.BNC, Stock Forum) shares climbed 46% to 36.5 cents on Tuesday as the Canadian biopharmaceutical company said it has engaged U.S.-based ... [Published Stockhouse Canada - May 14 2013]

Entities: Bioniche Life Sciences Inc, Animal Health, Stocks

First reported May 14 2013 - Updated May 15 2013 - 2 reports

Biovail Corp

Bioniche shareholders led by former Biovail execs renew bid to oust board

TORONTO - A group of dissident shareholders of Bioniche Life Sciences Inc. (TSX:BNC) is launching a renewed bid to replace the company's board of directors.The shareholders, led by former Biovail Corp. executives William Wells and Greg Gubitz, filed Tuesday ... [Published StockHouse USA - May 15 2013]

Entities: Biovail Corp, Bioniche Life Sciences Inc, William Wells, Toronto stock exchange

First reported May 14 2013 - Updated May 14 2013 - 1 reports

Manufacturing

Bioniche to divest animal health business

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, announced May 13 that it has engaged U.S.-based Evercore Partners to assist the Bioniche board of directors and management in its divestment of its animal ... [Published Feedstuffs - May 14 2013]

Entities: Bioniche Life Sciences Inc, Animal Health, Vaccine, Manufacturing

First reported May 13 2013 - Updated May 14 2013 - 3 reports

Bioniche looks to sell Animal Health

Bioniche Life Sciences (ASX:BNC) has engaged Evercore Partners to help manage the divestment of its Animal Health business. 14/ ... [Published Brisbane Times - May 14 2013]

Entities: Bioniche Life Sciences Inc, Animal Health, Evercore Partners Inc

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Bioniche Life Sciences Inc. (BNC) Reports Q3, Fiscal 2013 Results

Staying up-to-date has never been simpler. Sign up for the today! TORONTO , May 8, 2013 /CNW/ - (BNC.TO) (BNC.AX), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the third quarter of its 2013 ... [Published BioSpace - May 09 2013]

Entities: Bioniche Life Sciences Inc, Toronto, Fiscal Year

First reported May 09 2013 - Updated May 09 2013 - 2 reports

Concerned Bioniche Shareholders Respond To Latest Stalling Tactics Of Bioniche's Board Of Directors And Deteriorating Financial Position

TORONTOThis rejection of Mr. Wells' requisition is consistent with the Bioniche board's continued entrenchment of themselves and utter disregard for the company's shareholders, the owners of the company.The Concerned Shareholders are very disappointed ... [Published TheStreet.com - May 09 2013]

Entities: Bioniche Life Sciences Inc, Requisition, Fiduciary, Burn Rate, William Bill

First reported May 06 2013 - Updated May 06 2013 - 1 reports

Bioniche Life Sciences rejects call for shareholder meeting

Bioniche Life Sciences www.bioniche.com/Bioniche Life Sciences (ASX: BNC) is a Canadian biopharmaceutical company focused on the discovery, development, manufacturing and marketing of proprietary and innovative products for human and animal health markets ... [Published Proactive Investors Australia - May 06 2013]

Entities: Bioniche Life Sciences Inc, Australian Securities Exchange, Cattle, Animal Health, Escherichia Coli (E. Coli)

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Bioniche Life Sciences Determines Not To Call Dissident Shareholder's Meeting

Canadian biopharmaceutical company Bioniche Life Sciences Inc. (BNC.TO: Quote) said its board, on recommendation of a newly struck special committee, has determined that the dissident shareholder's request for a shareholder meeting received on April 25, ... [Published RTTNews.com - May 04 2013]

Entities: Bioniche Life Sciences Inc, Record Date, Requisition

Quotes

"Bioniche Life Sciences Inc. (BNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Published

"Bioniche Life Sciences, Inc. (BNC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" ... [Published Live-PR.com - 3 hours ago]

"Meanwhile, Animal Health product sales remain ahead of Fiscal 2012 on a year-to-date basis, and we are encouraged by the interest in Immunocidin and Sin Susto - two new companion animal products that were launched within the last six months" said Graeme McRae, president and CEO of Bioniche Life Sciences Inc

Bioniche Life Sciences Q3 net loss decreases [Published Zecco - May 22 2013]

Bioniche said its animal health business has built up since 1979 "to the point where it is profitable before research and development" and is officially the biggest Canadian-owned animal health company, with product lines in livestock reproduction, immunotherapeutics, equine performance...

E. coli vaccine maker to shed animal heath arm [Published Thompson Citizen - May 21 2013]

...James Rae, Chairman of the Board of Directors of Bioniche Life Sciences Inc. "Evercore's track record in successfully negotiating such transactions and its extensive network of contacts in the animal health industry make it an ideal firm to lead this exercise."

Bioniche Engages Evercore Partners To Assist In The Divestment Of Its Animal Health Business [Published Agri Marketing - May 21 2013]

More Content

sort by: Date \| Relevance
"Bioniche Life Sciences, Inc. (BNC) - Pharmaceu... [Published Live-PR.com - 3 hours ago]
Bioniche holders Wells, Gubitz slam animal heal... [Published Stockwatch - May 22 2013]
Concerned Shareholders of Bioniche Question Lat... [Published Digital Journal - May 22 2013]
Concerned Shareholders of Bioniche Question Lat... [Published Canada NewsWire - May 22 2013]
Bioniche Life Sciences Q3 net loss decreases [Published Zecco - May 22 2013]
Bioniche dissidents add Macci as director nominee [Published Stockwatch - May 21 2013]
E. coli vaccine maker to shed animal heath arm [Published Thompson Citizen - May 21 2013]
Bioniche Engages Evercore Partners To Assist In... [Published Agri Marketing - May 21 2013]
Bioniche Life Sciences, Inc. (BNC) - Pharmaceut... [Published TransWorldNews - May 18 2013]
Bioniche shareholders led by former Biovail exe... [Published StockHouse USA - May 15 2013]
Bioniche shareholders led by former Biovail exe... [Published Brandon Sun - May 14 2013]
Bioniche Life Sciences shares surge on unit sal... [Published Stockhouse Canada - May 14 2013]
Exploration junior up 20% on drill results [Published StockHouse USA - May 14 2013]
Fitch: Strategic Actavis/Warner Combo Could Pre... [Published Business Wire - May 14 2013]
Bioniche to divest animal health business [Published Feedstuffs - May 14 2013]
ACT, THRX Hit All-time High, NSPH Makes A Big M... [Published RTTNews.com - May 14 2013]
Bioniche looks to sell Animal Health [Published Brisbane Times - May 14 2013]
Bioniche Life Sciences engages Evercore Partner... [Published Proactive Investors Australia - May 14 2013]
Bioniche Engages Evercore Partners to Assist in... [Published Barchart - May 13 2013]
Bioniche Engages Evercore Partners to Assist in... [Published Financial Services - May 13 2013]
Bioniche Life Sciences Inc. (BNC) Reports Q3, F... [Published BioSpace - May 09 2013]
Bioniche Life Sciences Inc. Reports Q3, Fiscal ... [Published BioSpace - May 09 2013]
Concerned Bioniche Shareholders Respond To Late... [Published TheStreet.com - May 09 2013]
Concerned Bioniche Shareholders Respond to Late... [Published PR Newswire - May 09 2013]
Concerned Bioniche Shareholders Respond to Late... [Published Canada NewsWire - May 09 2013]
Bioniche Life Sciences Inc. Reports Q3, Fiscal ... [Published NewsBlaze - May 08 2013]
Bioniche Life Sciences Inc. Reports Q3, Fiscal ... [Published PR Newswire - May 08 2013]
Bioniche Life Sciences Inc. Reports Q3, Fiscal ... [Published Individual.com - May 08 2013]
Is Your C-Suite Improving or Hindering Your Com... [Published eyeforpharma.com - May 08 2013]
Bioniche refuses to hold requested shareholder ... [Published Stockwatch - May 06 2013]

sort by: Date \| Relevance
Court Report [Published Patent Docs - Apr 29 2013] By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Mayo Foundation for Medical Education and Research v. ARUP Laboratories, Inc. 0:13-cv-00933; filed April 22, 2013 in the District Court ...
Monday Deal Review: April 8, 2013 [Published The Cross-Border Biotech Blog - Apr 08 2013] Welcome to your Monday Biotech Deal Review for April 8, 2013! After a hiatus last week due to the holiday, this week we have a lot of activity to cover. Valeant, in particular has been quite busy, being forced to up their bid for Obagi to $24.00 in ...
Monday Deal Review: March 11, 2013 [Published The Cross-Border Biotech Blog - Mar 11 2013] Welcome to your Monday Biotech Deal Review for March 11, 2013! The past week saw significant activity in the investment space, so click through to review a busy week’s worth of biotech news! Investment Abattis Biologix Corporation ( CNSX: FLU ...
2012 Canadian Healthcare Financings – strong bu... [Published The Cross-Border Biotech Blog - Feb 22 2013] Large profitable public companies had no problem completing financings, especially those in the seniors housing and long-term care field (the gross proceeds for this category are listed below). Catamaran – $541.8 M (equity)Chartwell Seniors Housing ...
Monday Deal Review: February 4, 2013 [Published The Cross-Border Biotech Blog - Feb 04 2013] Welcome to your Monday Biotech Deal Review for February 4, 2013! This week saw significant activity in the sector generally On the M&A side, Valeant continued their ongoing acquisition strategy, buying the Russian Natur Product International, a primarily ...